An angel group based in the Mid-Atlantic region of the United States is currently seeking new investment opportunities in the life sciences space. The firm has no set timeframe to make an allocation, and is thus always opportunistically looking for new firms in the space. They would therefore invest in a new firm within the next six months if a compelling opportunity were uncovered. The group typically invests around $1-2 million per firm.
The firm is interested in biotech firms creating therapeutics, as well as those developing diagnostics, and is also looking for firms in the medtech space. The firm is seeking to invest in pre-revenue companies, and will consider firms in the medtech space that are in development, or firms that have a prototype.
Next Phase Newsletter 
Leave a comment